This paper describes the antitumoral activity of branched-chain fatty acid (BCFA) in human breast cancer cells with an emphasis on its effect on fatty acid biosynthe sis. First, the relationship between chain-length and antitumoral activity was studied. The highest activity was observed with iso-16:0, and the activity decreased with increase or decrease of the chain-lengths from C 16:0. Anteiso-BCFA, as well as iso-series, was cytotoxic to the breast cancer cells. Cytotoxicity of BCFA was comparable to that of conjugated linoleic acid known as antitumoral fatty acid. Incubation of breast cancer cells with BCFA (13 -methyltetradecanoic acid) significantly reduced the [14C] acetate incorporation into free fatty acid and fatty acid esters, showing the inhibition of fatty acid biosynthesis by BCFA. Examination of substrate level effect found that BCFA slightly inhibited fatty acid synthetase and acetyl-CoA carboxylase, and significantly the glucose-6-phosphate dehydrogenase which was the main NADPH generating system in breast cancer cells. The present study thus suggests that BCFA synthetically lowers the fatty acid biosynthesis by reducing the pre cursors, in addition to its direct inhibitory effect on fatty acid synthetase.
The branched-chain fatty acid (BCFA) occurs natu rally in a particular bacteria such as Bacilli species (1), or alternatively in some dairy products (2, 3) . A satu rated BCFA, 13-methyltetradecanoic acid (13-MTD), was purified from a soy-fermentation product as an antitumor compound (4) . It was also found that BCFA induced apoptotic cell death of human cancer cells (4) .
The regulation of cell growth is a homeostatic bal ance between stimulatory and inhibitory signals. The negative growth control by induction of apoptosis attracted many investigators' attention, and provided a strategy for a treatment of malignancies (5) (6) (7) (8) (9) (10) . Com plex signal transduction systems are involved in the induction of apoptosis (11, 12) . This leaves the question on the mechanisms of apoptosis induction by BCFA unanswered.
The malignant tissues express high levels of fatty acid synthetase (13) (14) (15) (16) (17) (18) (19) , which led to the notion that fatty acid synthetase is a target for anticancer drug develop ment (9) . It has been proposed that the inhibition of fatty acid synthetase (FAS) triggers the signal transduc tion flux toward induction of apoptosis, and causes the cell death (6, 8) . It thus can be expected that fatty acids exert their biological effects by modulation of fatty acid 
RESULTS
Although the previous studies on anti-tumor activity of soy-fermentation product found the branched-chain fatty acids (BCFAs) to be anti-tumor agents, no informa tion on their structural characteristics relevant to their biological activity has been available. Therefore, the present study first examined the relationship between chain-length and their anti-tumor activity. Figure 1 shows the cytotoxicities of iso-series BCFAs with varied chain-lengths. The highest activity was observed with iso-16:0, and the activity decreased with increase or decrease of the chain-length from C16:0.
Two types of major BCFAs occur in nature: iso-series and anteiso-series (1). Anteiso-15:0 having methyl branching at antepenultimate (anteiso) positions show ed the cytotoxicity comparable to iso-15:0 (Fig. 2) . Thus the D50 of both iso-15:0 and anteiso-15:0 were lower than corresponding straight-chain fatty acids (SCFA). Several lines of studies have showed that certain poly unsaturated fatty acids (PUFAs) had a selective cyto toxic effect on tumor cells and minimal or no effect on normal cells (29) . By analogy, selective cytotoxicity of BCFA was studied with normal and tumor lung cells (Fig. 3) . 13-Methyltetradecanoic acid (13-MTD; iso-15:0) was toxic to both normal and tumor cells with higher cytotoxicity than SOFA, n-C14:0 (compare Fig. 3A and  3B) .
Conjugated-linoleic acids (CLAs) have been reported to be antitumoral fatty acids (30, 31) . Two types of bio logically active CLAs are known: cis-9, trans-11 and trans-10, cis-12-CLA). The former was the principal dietary form of CLA, and used in this experiment as a reference. Comparison of cytotoxicity revealed that cytotoxicity of 13-MTD was almost the same as CLA (Fig.4) . The same experiment on the SKBR-3 cells reproduced the similar results as shown in Fig. 4 (data not shown).
There has been a notion that fatty acid exerts its bio logical activity by affecting the fatty acid or lipid metab olism (32) . We therefore examined the effect of MTD on the lipid biosynthesis from [14C] acetate. SKBR-3 cells were considered to be ideal for these studies because they express the highest cellular levels of FAS yet described in human established cell lines (33) . The highest incorporation of [14C] acetate was noted with phospholipids, which increased linearly up to 4 ( Cancer cells treated with 13-MTD, myristic acid (n -14:0) and CLA were incubated with [14C] acetate for 4h (Fig. 6) . The trypan blue dye exclusion test found comparable cell viability between treatments with fatty acids. The sum of [14C] label incorporated into free fatty acids and fatty acid esters (phospholipid+triacyl glycerol+cholesterol ester) was lower in 13-MTD than myristic acid, showing an inhibition of fatty acid bio synthesis by 13-MTD (Fig. 6A) . The incorporation was high with phospholipid, triacylglycerol, free fatty acid, cholesterol and cholesterol ester in the order of magni tude (Fig. 6B) . 13-MTD significantly lowered the incor poration of [14C] acetate into triacylglycerol and free fatty acid, compared with myristic acid. A decreased [14C] acetate incorporation was also noted with CLA, but to a rather lower extent compared with 13-MTD. The myristic acid enhanced the transformation of free fatty acid into triacylglycerols more than 13-MTD or CLA. 13-MTD decreased the cholesterogenesis in the breast cancer cells, as well as fatty acid biosynthesis. 13-MTD decreased the fatty acid biosynthesis in breast cancer cells. The in vitro effect of 13-MTD on the enzymes involved in fatty acid biosynthesis was studied (Table 1) . Because limited amounts of enzymes were available from tissue culture, the enzyme's source was from rat liver. Five enzyme activities were assayed; fatty acid synthetase (FAS), acetyl-CoA carboxylase, glucose -6-phosphate dehydrogenase (G6PDH), ATP-citrate lyase and malic enzyme ( Table 1) . Concentration of fatty acid in the reaction mixture was 0.25mM compa rable to that in the culture medium. 13-MTD inhibited the FAS activity (Table 1) . CLA also showed an inhibition of FAS to a greater extent than 13-MTD. Acetyl-CoA carboxylase was inhibited by both 13-MTD and CLA as was the case for fatty acid syn thetase. 13-MTD and myristic acid, but not CLA, inhib ited G6PDH. ATP-citrate lyase was elevated by vehicle solution, and no difference was noted between fatty acid treatments. Malic enzyme was slightly lowered by all fatty acids tested. No difference between treatments was also notable.
Of the enzymes involved in the fatty acid biosynthe sis, FAS, acetyl-CoA carboxylase and G 6PDH from rat liver were inhibited in vitro by 13-MTD. We therefore focused on these enzyme activities of human breast cancer cells. In the case of FAS assay, limited amounts of enzyme proteins from cancer cells did not allow to apply the colorimetric method used for the rat liver enzyme. For this reason, FAS activity was assayed by incorpora tion of [14C] malonyl-CoA into fatty acids (26) . A decreasing tendency for FAS was seen with 13-MTD (Fig. 7) , while CLA lowered the activity to a greater extent than 13-MTD. 13-MTD suppressed G6PDH from cancer cells as was the case for rat liver enzyme (Fig. 8) . fatty acid biosynthesis, and inhibition of FAS induces the apoptosis in human cancer cells (5) (6) (7) (8) . Previous study also showed that BCFA induces apoptotic cell death, and inhibits in vivo growth of human cancer cells (4) . The authors assumed that the FAS inhibition could be responsible for the growth inhibition of cancer cells by BCFAs. This assumption is quite reasonable because it is possible that BCFAs affect the cell replication pro cess through modulation of fatty acid metabolism.
As we assumed, BCFAs inhibited the fatty acid bio synthesis in the cultured SKBR-3 breast cancer cells (Fig. 6) . Examination of the effect on the rat liver enzymes involved in fatty acid biosynthesis revealed that BCFA (13-MTD) was inhibitory to FAS, acetyl-CoA carboxylase and G6PDH. CLA, as well as 13-MTD, was an inhibitor to FAS and acetyl-CoA carboxylase, but not to G6PDH. Thus the difference between 13-MTD and CLA appeared to lie in the effect on G6PDH. It was shown that palmitoyl-CoA inhibits yeast G6PDH by dis sociating the tetrameric enzyme into an inactive dimeric subunit (34). 13-MTD may decrease the mam malian G6PDH by a similar mechanism.
G6PDH is the first enzyme in the hexose monophos phate shunt which provides important precursors for both fatty acid and nucleotide synthesis. For this reason 13-MTD might synthetically lower the fatty acid bio synthesis by reducing the substrate NADPH in addition to its direct inhibitory effect on FAS. Furthermore, G6PDH is an interface enzyme between the glycolytic pathway and hexose monophosphate shunt. Inhibition of G6PDH therefore decreases both substrates for fatty acid and nucleotide biosynthesis, BCFA as 13-MTD may affect the cell dynamics by reducing substrates for both DNA duplication and membrane biogenesis. 13-MTD was shown to be toxic against both cancer and normal lung cells in vitro (Fig. 3) . However, this does not necessarily indicate that 13-MTD damages both tumor and normal tissues in vivo, It has been shown that 13-MTD effectively inhibited in vivo growth of various cancer cells without significant side effects (4). Cancer cells expressed higher levels of FAS, and are more dependent on the fatty acid biosynthesis pathway for survival than normal cells (10) . This leads to to the accepted view that inhibition of FAS is selectively cyto toxic to human cancer cells in vivo (7, 10) . Rapid grow ing normal and cancer cells may evenly require an increased fatty acid biosynthesis, However, normal tis sue does not need to undergo rapid regenerations under normal situations. Therefore, demand for fatty acid syn thesis may be smaller in the normal tissues than cancer cells, which may explain in part the selective cytotoxic ity of FAS inhibition against cancer cells. Of these tis sues, however, rapidly regenerating tissues such as intestinal epithelium or bone marrow may need more fatty acid synthesis than the other tissues even under normal conditions. For this reason, the effect of FAS inhibition may differ with the tissues. Care should be taken when referring to the effect of FAS inhibition on the rapidly proliferating tissues, and no reference to this point has been made in the previous studies.
Inhibition of FAS by cerulenin causes a rapid accu mulation of malonyl-CoA, which could be a trigger of the apoptotic cell death (35) (36) (37) . Furthermore, accu mulation of malonyl-CoA inhibits carnitine palmitoyl transferase-1, hence fatty acid oxidation (35) . Com bined inhibition of fatty acid biosynthesis and oxidation seems to explain the cytotoxicity of cerulenin (35) . For this reason, the forthcoming study should focus more on the insight into the detailed mechanism of BCFA cytotoxicity.
